Vivakor, Inc. (VIVK) earnings
VIVK earnings moved a median of -0.13% by the close. Quarterly and annual VIVK reports and results, each read against the price at its own news timestamp. Back to the VIVK overview →
28 measured VIVK earnings events.
Where these VIVK earnings landedvs 26 measured VIVK earnings reactions
| Middle 50% of VIVK earnings reactions | -3.15% to +1.84% |
|---|---|
| Median reaction (to close) | -0.13% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 VIVK earnings events with a measured close landed between -3.15% and +1.84%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| VIVAKOR PROVIDES Q3 2026 REVENUE GUIDANCE OF APPROXIMATELY $270 MILLION | Press release | -0.95% | -14.18% | |
| Form 10-Q Vivakor, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.84% | +0.85% | |
| Form NT 10-Q Vivakor, Inc. For: Jun 30 | SEC filing · Form NT | +0.83% | +0.83% | |
| Vivakor Reports First Quarter 2026 Financial Results | Press release | -4.07% | -10.00% | |
| Form 10-Q Vivakor, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.53% | -0.76% | |
| Form NT 10-Q Vivakor, Inc. For: Mar 31 | SEC filing · Form NT | -1.71% | +1.43% | |
| Form 10-K Vivakor, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form NT 10-K Vivakor, Inc. For: Dec 31 | SEC filing · Form NT | — | — | |
| Form 10-Q Vivakor, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.54% | -13.17% | |
| Form NT 10-Q Vivakor, Inc. For: Sep 30 | SEC filing · Form NT | -1.37% | -18.63% | |
| Form 10-Q Vivakor, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.55% | -1.18% | |
| Form NT 10-Q Vivakor, Inc. For: Jun 30 | SEC filing · Form NT | +2.33% | -3.52% | |
| Form 10-Q Vivakor, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.13% | -2.38% | |
| Form NT 10-Q Vivakor, Inc. For: Mar 31 | SEC filing · Form NT | — | -2.75% | |
| Form 10-K/A Vivakor, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.96% | -3.58% | |
| Form 10-K Vivakor, Inc. For: Dec 31 | SEC filing · Form 10-K | +18.43% | +28.84% | |
| Form NT 10-K Vivakor, Inc. For: Dec 31 | SEC filing · Form NT | +10.81% | +13.37% | |
| Form 10-Q Vivakor, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +1.28% | |
| Form NT 10-Q Vivakor, Inc. For: Sep 30 | SEC filing · Form NT | +0.00% | -3.29% | |
| Form 10-Q Vivakor, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +1.01% | |
| Form NT 10-Q Vivakor, Inc. For: Jun 30 | SEC filing · Form NT | — | +0.50% | |
| Form 10-Q Vivakor, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -2.27% | |
| Form NT 10-Q Vivakor, Inc. For: Mar 31 | SEC filing · Form NT | -0.40% | +2.40% | |
| Form 10-K Vivakor, Inc. For: Dec 31 | SEC filing · Form 10-K | +5.87% | +1.98% | |
| Form NT 10-K Vivakor, Inc. For: Dec 31 | SEC filing · Form NT | +0.25% | -1.78% | |
| Vivakor Reports 39% Revenue Growth to $16.3 Million Revenue for Third Quarter 2023 | Press release | +0.00% | +4.36% | |
| Form 10-Q Vivakor, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +11.79% | |
| Form NT 10-Q Vivakor, Inc. For: Sep 30 | SEC filing · Form NT | +8.77% | +7.38% |
Keep exploring
More VIVK: analyst actions → · SEC filings → · VIVK overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | 244 | +0.06% | 55% |
| NextTrip, Inc. (NTRP) | 244 | -0.41% | 38% |
| IKANG HEALTH CARE GROUP (KANG) | 242 | -0.07% | 44% |
| Adial Pharmaceuticals, Inc (ADIL) | 241 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.